Arvinas
ARVN • NASDAQ
Arvinas is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Randy Teel, with a market cap of $646.0M.
CEORandy Teel
Next Earnings
Upcoming earnings announcement for Arvinas
Date
Thursday, April 30, 2026 (in 4 weeks)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.95
Revenue Estimate
$17.1M
Earnings History
Past 12 earnings reports for Arvinas
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | -$1.10Est: -$0.56 | -96.4% | $9.5MEst: $35.6M | -73.3% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.48Est: -$0.75 | +36.0% | $41.9MEst: $26.9M | +55.7% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.84Est: -$0.88 | +4.5% | $22.4MEst: $39.8M | -43.8% | 10-Q |
| May 1, 2025 | Q1 2025 | $1.14Est: -$0.97 | +217.5% | $188.8MEst: $41.9M | +350.9% | 10-Q |
| Feb 11, 2025 | Q4 2024 | -$0.63Est: -$0.96 | +34.4% | $59.2MEst: $62.8M | -5.7% | 10-K |
| Oct 30, 2024 | Q3 2024 | -$0.68Est: -$0.96 | +29.2% | $102.4MEst: $57.4M | +78.3% | 10-Q |
| Jul 30, 2024 | Q2 2024 | -$0.49Est: -$0.86 | +43.0% | $76.5MEst: $55.3M | +38.4% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.97Est: -$1.42 | +31.7% | $25.3MEst: $35.1M | -27.9% | 10-Q |
| Feb 27, 2024 | Q4 2023 | -$2.53Est: -$1.28 | -97.7% | -$43.1MEst: $49.3M | -187.4% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$1.18Est: -$1.57 | +24.8% | $34.6MEst: $40.5M | -14.6% | — |
| Aug 8, 2023 | Q2 2023 | -$1.25Est: -$1.65 | +24.2% | $54.5MEst: $29.4M | +85.4% | 10-Q |
| May 5, 2023 | Q1 2023 | -$1.54Est: -$1.51 | -2.0% | $32.5MEst: $27.7M | +17.3% | — |